Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.520
+0.110 (7.80%)
Jan 21, 2025, 4:00 PM EST - Market closed
Company Description
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum.
The company’s medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.
Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023.
Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Envoy Medical, Inc.
| Country | United States |
| Founded | 1995 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 34 |
| CEO | Brent Lucas |
Contact Details
Address: 4875 White Bear Parkway White Bear Lake, Minnesota 55110 United States | |
| Phone | 877 900 3277 |
| Website | envoymedical.com |
Stock Details
| Ticker Symbol | COCH |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840877 |
| ISIN Number | US29415V1098 |
| Employer ID | 86-1369123 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Brent T. Lucas Esq. | Chief Executive Officer and Director |
| David R. Wells | Chief Financial Officer |
| Karin Simonson | Vice President, General Counsel and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 21, 2025 | 424B5 | Filing |
| Jan 21, 2025 | 8-K | Current Report |
| Dec 26, 2024 | SCHEDULE 13D | Filing |
| Dec 23, 2024 | 424B3 | Prospectus |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 20, 2024 | 424B3 | Prospectus |
| Dec 20, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 424B3 | Prospectus |
| Dec 17, 2024 | 8-K | Current Report |
| Nov 20, 2024 | 8-K | Current Report |